nach oben

Endocrine Pathology

Erschienen in:

09.02.2023

Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Thyroid and Mucoepidermoid Carcinoma of the Thyroid: What’s in a Name?

verfasst von: Virginia A. LiVolsi

Erschienen in: Endocrine Pathology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

What do sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) and mucoepidermoid carcinoma of the thyroid (MEC) have in common? They are both primary thyroid carcinomas and they share part of their diagnostic names. Beyond that, similarities are absent (in the opinion of the present author). Unfortunately, the literature on these two entities has led to confusion as to the relationships of the lesions to each other and also, to what is the cell of origin. …

Le HT, Nguyen TPX, Hirokawa M, et al., Primary thyroid mucoepidermoid carcinoma (MEC) is clinically, prognostically and molecularly different from sclerosing MEC with eosinophilia: A multicenter and integrated study. Endocr Pathol 2022 Nov 17. https://doi.org/10.1007/s12022-022-09741-1. Epub ahead of print. PMID: 36394696.

Shah AA, LaFortune K, Miller C, et al. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity. Mod Pathol 2017; 30: 329- 339.CrossRefPubMed

Baloch, ZW Solomon A, LiVolsi VA. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland:A report of nine cases. Mod Pathol. 2000;1 3:802–807.

Baloch ZW, Asa SL, Barletta JA, et al Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 2022; 33: 27- 63.CrossRefPubMed

Farhat NA, Onenerk AM, Krane J, et al., Primary benign and malignant thyroid neoplasms with signet ring cells, Am J Clin Pathol 2017;148:251-258.CrossRefPubMed

Titel: Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Thyroid and Mucoepidermoid Carcinoma of the Thyroid: What’s in a Name?
verfasst von: Virginia A. LiVolsi
Publikationsdatum: 09.02.2023
Verlag: Springer US
Erschienen in: Endocrine Pathology / Ausgabe 1/2023
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI: https://doi.org/10.1007/s12022-023-09754-4

Springer Medizin

Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Thyroid and Mucoepidermoid Carcinoma of the Thyroid: What’s in a Name?

Excerpt

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Thyroblastoma—a Primitive Multilineage Thyroid Neoplasm with Somatic DICER1 Alteration

The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation

The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology

The Spectrum of Familial Pituitary Neuroendocrine Tumors

High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas

Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie